Pier 88 Investment Partners LLC Rocket Pharmaceuticals, Inc. Transaction History
Pier 88 Investment Partners LLC
- $76.1 Million
- Q3 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 32,490 shares of RCKT stock, worth $375,584. This represents 0.79% of its overall portfolio holdings.
Number of Shares
32,490
Previous 30,900
5.15%
Holding current value
$375,584
Previous $665,000
9.77%
% of portfolio
0.79%
Previous 0.76%
Shares
3 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$204 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$130 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$71.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$64 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$51.9 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $875M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...